上海医药：第八届董事会第二十四次会议决议公告

Core Viewpoint - Shanghai Pharmaceuticals announced the approval of the "2025 Semi-Annual Report and Summary" by the company's eighth board of directors during its 24th meeting [2] Group 1 - The announcement was made on the evening of August 28 [2] - The report includes financial performance and strategic insights for the first half of 2025 [2]